ELVN
Enliven Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
46.97USD+1.645%(+0.76)1,123,209
Pre-marketOct 2, 2026 9:08:30 AM EDT
47.21USD+2.164%(+1.00)
Loading…
Loading…
3.44B
Healthcare
Biotechnology
HQ
Boulder, CO, USA
Previous Close
$46.21
Beta
1.00
52-Week High
$62.32 2026-08-05
52-Week Low
$14.79 2026-01-06
SMA 50
$55.10
SMA 200
$40.42
Avg. Vol 10D
1.22M
Avg. Vol 30D
1.28M
Avg. Vol 90D
1.40M
Relative Vol
0.88
73.27M
45.61M
62.25%
8,620,503
18.90%
9.01
42%/58%
73.67%
58.72%
0.2800%
500,000
31
14,472
28,913
Nov 11, 2026 (37d)
Oct 2, 2026
Oct 1, 2026
These ten healthcare stocks posted the biggest one-month losses · 
Seeking Alpha
Enliven Therapeutics stock initiated at Overweight by JPMorgan · 
Investing.com
Sep 28, 2026
Sep 22, 2026
Enliven Therapeutics CMO Helen Collins sells $251k in shares · Investing.com
ELVN Profile
enliven therapeutics focuses on the discovery and development of next generation small molecule treatments for cancer. we are backed by top-tier life science venture funds. we seek experienced and passionate drug hunters to join our team as we grow our r&d organization in boulder, co.
ELVN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 46.01 | 2026-09-28 | +2.10% | 2.015 |
| 1M | 59.32 | 2026-09-04 | -20.81% | 0.912 |
| 3M | 50.01 | 2026-07-06 | -6.06% | 1.351 |
| 6M | 38.94 | 2026-04-06 | +20.64% | 0.559 |
| 1Y | 19.61 | 2025-10-03 | +139.56% | 1.000 |
| 2Y | 27.53 | 2024-10-04 | +70.64% | — |
| 5Y | 21.00 | 2023-02-27 | +123.70% | 1.306 |
ELVN Stock Summary
Enliven Therapeutics, Inc. Common Stock (NASDAQ:ELVN) stock price today is $46.98, and today's volume is 1,123,209. ELVN is up 1.661% today. The 30 day average volume is 1.28M. ELVN market cap is $3.44B with 73.27M shares outstanding.